Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1433 to 1482 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase iii alpha (ec 5.99.1.2). [source:swissprot;acc:q13472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5692.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6131.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07719\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin viia. [source:swissprot;acc:q13402]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5759.68\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6203.63\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07708\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 b (ec 6.3.2.19) (ubiquitin-protein ligase b) (ubiquitin carrier protein b) (hr6b) (hhr6b) (e2-17 kda). [source:swissprot;acc:p23567]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 a (ec 6.3.2.19) (ubiquitin-protein ligase a) (ubiquitin carrier protein a) (hr6a) (hhr6a). [source:swissprot;acc:p49459]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase, mitochondrial precursor (ec 1.1.99.5) (gpd-m) (gpdh-m). [source:swissprot;acc:p43304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6089.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6558.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07695\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec10 (hsec10). [source:swissprot;acc:o00471]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6721.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7238.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07693\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5658.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6093.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07683\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal membrane protein pex14 (peroxin-14) (peroxisomal membrane anchor protein pex14) (pts1 receptor docking protein). [source:swissprot;acc:o75381]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6522.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7023.77\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07678\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 7 (ec 3.4.25.1) (proteasome subunit rc6-1) (proteasome subunit xapc7). [source:swissprot;acc:o14818]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6216.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6693.38\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 7-like (ec 3.4.25.1). [source:swissprot;acc:q8taa3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6216.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6693.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07674\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ketohexokinase (ec 2.7.1.3) (hepatic fructokinase). [source:swissprot;acc:p50053]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5450.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5869.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cd109; gov system alloantigens on platelets. [source:refseq;acc:nm\_133493]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5117.85\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5510.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07671\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase nima-interacting 1 (ec 5.2.1.8) (rotamase pin1) (ppiase pin1). [source:swissprot;acc:q13526]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-4 (iroquois homeobox protein 4). [source:swissprot;acc:p78413]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dpy-30-like protein. [source:swissprot;acc:q9c005]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5602.01\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6031.05\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07659\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab coupling protein; rab-interacting recycling protein; rab effector protein; rab11-family interacting protein 1. [source:refseq;acc:nm\_025151]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neighbor of cox4. [source:swissprot;acc:o43402]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein c14orf122 (cgi-112). [source:swissprot;acc:q9y3b6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein sumo-1 conjugating enzyme (ec 6.3.2.19) (sumo- 1-protein ligase) (ubiquitin carrier protein) (ubiquitin-conjugating enzyme ubce2a) (p18). [source:swissprot;acc:p50550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5770.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6210.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07623\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1455\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim protein (similar to rat protein kinase c-binding enigma); enigma homolog. [source:refseq;acc:nm\_006457]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07615\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
e1a binding protein p400; p400 swi2/snf2-related protein; cagh32 protein; trinucleotide repeat containing 12. [source:refseq;acc:nm\_015409]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.01\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07612\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
collagen alpha 5(iv) chain precursor. [source:swissprot;acc:p29400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.98\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1458\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l24. [source:refseq;acc:nm\_024540]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5672.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6104.01\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1459\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
65 kda yes-associated protein (yap65). [source:swissprot;acc:p46937]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1460\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p29ing4; candidate tumor suppressor p33 ing1 homolog. [source:refseq;acc:nm\_016162]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5696.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6130.26\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1461\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
9 kda protein. [source:swissprot;acc:p13994]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.01\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1462\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional co-activator with pdz-binding motif (taz). [source:refseq;acc:nm\_015472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.99\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1463\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
collagen alpha 3(iv) chain precursor (goodpasture antigen). [source:swissprot;acc:q01955]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1464\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zasp protein (fragment). [source:sptrembl;acc:q9y4z3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5671.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase [nad+], cytoplasmic (ec 1.1.1.8) (gpd-c) (gpdh-c). [source:swissprot;acc:p21695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5686.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6119.36\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07608\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1466\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 5 precursor (ec 3.4.25.1) (proteasome epsilon chain) (macropain epsilon chain) (multicatalytic endopeptidase complex epsilon chain) (proteasome subunit x) (proteasome chain 6) (proteasome subunit mb1). [source:swissprot;acc:p28074]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6523.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7019.44\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1467\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p47 protein isoform a. [source:refseq;acc:nm\_016143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6444.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6932.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07572\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5473.09\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5887.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07571\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine aminotransferase, mitochondrial precursor (ec 2.6.1.13) (ornithine--oxo-acid aminotransferase). [source:swissprot;acc:p04181]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s8. [source:swissprot;acc:p09058]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5659.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6087.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07564\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5984.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6435.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calmegin precursor. [source:swissprot;acc:o14967]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5910.06\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6355.08\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0753\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calnexin precursor (major histocompatibility complex class i antigen-binding protein p88) (p90) (ip90). [source:swissprot;acc:p27824]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna (guanine-7-) methyltransferase. [source:refseq;acc:nm\_003799]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 2 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 2) (ppt-2) (g14). [source:swissprot;acc:q9umr5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3687.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3429.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07523\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-7 (activating transcription factor 7) (transcription factor atf-a). [source:swissprot;acc:p17544]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5659.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6084.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07518\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-alpha (hnf-3a) (forkhead box protein a1). [source:swissprot;acc:p55317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5787.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6221.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-2 (activating transcription factor 2) (camp response element binding protein cre- bp1) (hb16). [source:swissprot;acc:p15336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5660.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6085.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07509\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
egf-like-domain, multiple 7; neu1 protein. [source:refseq;acc:nm\_016215]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3688.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3431.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leng5 protein. [source:refseq;acc:nm\_024075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5372.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5775.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07501\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/